CDEX, Inc. Delivers First Production ValiMed Medication Validation System.ROCKVILLE, Md. -- CDEX CDEX Center for Deep Earth Exploration CDEX Compact Disk Engineering Data Exchange CDEX Checkstub Data Exchange CDEX Combat Developments Experimentation Center CDEX Chemical Detection Excellence (CDEX, Inc; Tucson, AZ) CDEX Cdrom Extension , Inc. (CEXI CEXI Cryogenic Experts, Inc. (Ventura, CA, USA) .OB) announced today that it has delivered the first ValiMed Medication Validation System production units in the initial installment of the systems purchased by Baxa Corporation (www.baxa.com) under their reseller agreement with CDEX (www.cdex-inc.com). The ValiMed Medication Validation System is designed to verify narcotic narcotic, any of a number of substances that have a depressant effect on the nervous system. The chief narcotic drugs are opium, its constituents morphine and codeine, and the morphine derivative heroin. See also drug addiction and drug abuse. disposal and validate pharmaceuticals, including concentration and diluents, in patient medications. The first production units were prepared to verify 33 medications (nine narcotics narcotics n. 1) techinically, drugs which dull the senses. 2) a popular generic term for drugs which cannot be legally possessed, sold, or transported except for medicinal uses for which a physician or dentist's prescription is required. and 24 medications) for both doses and diluents. The information obtained from CDEX beta partners has permitted the company to incorporate significant changes to the system from the original design. The current configuration can validate narcotic disposal of such narcotics as Fentanyl fentanyl /fen·ta·nyl/ (fen´tah-nil) an opioid analgesic; the citrate salt is used as an adjunct to anesthesia, in the induction and maintenance of anesthesia, in combination with droperidol (or similar agent) as a neuroleptanalgesic, and at 50 mcg/ml and differentiate patient care drugs such as Epinephrine at 0.005 mg/ml and Epinephrine at 0.01 mg/ml. "The delivery of the first ValiMed production units marks a significant milestone in the CDEX growth strategy. The shipment of the ValiMed systems has positioned the company to focus on overall market penetration Noun 1. market penetration - the extent to which a product is recognized and bought by customers in a particular market penetration - the act of entering into or through something; "the penetration of upper management by women" for the ValiMed product. Our proven production capabilities coupled with our recent TUV (Technischer Überwachungs-Verein) Literally "Technical Watch-Over Association." A German certifying body involved with product safety for the European community. certification has opened significant opportunities for us both in the U.S. and overseas," stated Jim Griffin, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CDEX, Inc. The ValiMed medication library currently consists of 33 narcotics and patient care medications, and is scheduled to be expanded to more than 140 medications, doses and diluents, by the end of the year. ValiMed's improved capabilities and an expanding medication library will ensure that the system becomes an essential tool for improving patient safety. About CDEX, Inc. CDEX, Inc. is a technology development company with a current focus on developing and marketing products using chemical detection and validation technologies. At present, CDEX is devoting its resources to two distinct areas: (i) identification of substances of concern (e.g., explosives and illegal drugs for homeland security Noun 1. Homeland Security - the federal department that administers all matters relating to homeland security Department of Homeland Security executive department - a federal department in the executive branch of the government of the United States ); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance (e.g., validation of prescription medication and detection of counterfeit or sub-par products for brand protection). ValiMed is one line of CDEX products for the healthcare market. CDEX is headquartered in Rockville, Maryland with its research and development laboratory in Tucson, Arizona. For more information, visit www.cdex-inc.com and www.valimed.com. Any statements made in this press release which contain information that is not historical are essentially forward-looking. Many forward-looking statements can be identified by the use of words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks are detailed from time-to-time in filings with the Securities and Exchange Commission. There is no obligation to publicly update any forward-looking statements. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion